(Q28279918)

3

0 references

Franco Regli

11

object named as

F Regli

0 references

author name string

P Aebischer

1

0 references

M Schluep

2

0 references

J M Joseph

4

0 references

B Heyd

6

0 references

M Goddard

7

0 references

J P Hammang

8

0 references

A D Zurn

9

0 references

A C Kato

10

0 references

E E Baetge

Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy

12

0 references

language of work or name

English

0 references

publication date

June 1996

0 references

published in

Nature Medicine

0 references

volume

2

0 references

issue

6

0 references

page(s)

696-9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/NM0696-696

Insulin-like growth factor-I: potential for treatment of motor neuronal disorders

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

Polymer Encapsulated Cell Lines Genetically Engineered to Release Ciliary Neurotrophic Factor Can Slow Down Progressive Motor Neuronopathy in the Mouse

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

The pharmacokinetics of subcutaneously administered recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis: relation to parameters of the acute-phase response. The ALS CNTF Treatment Study (ACTS) Phase

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

A phase I study of recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

Ciliary neurotrophic factor: Pharmacokinetics and acute-phase response in rat

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF.

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

Quantitative motor assessment in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

The administration of guanidine in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

Members of several gene families influence survival of rat motoneurons in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones.

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

The neurotrophins BDNF, NT-3 and NT-4/5, but not NGF, up-regulate the cholinergic phenotype of developing motor neurons.

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

Overlapping and additive effects of neurotrophins and CNTF on cultured human spinal cord neurons

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-696

7 January 2021

Identifiers

DOI

10.1038/NM0696-696

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

8640564

1 reference

Consolidated OpenCitations Corpus – April 2017